MD: financial statements from SEC — TradeAlmanac

Pediatrix Medical Group, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	1.91bn	2.01bn
Selling, general and administrative	241m	238m
Operating expenses	1.71bn	2.08bn
Operating income	209m	−69m
Pre-tax income	216m	−101m
Income tax	51m	−2m
Net income	165m	−99m
Earnings per share	1.97	−1.19
Earnings per share, diluted	1.94	−1.19
Weighted average shares	84m	83m
Weighted average shares, diluted	85m	83m

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	206m	375m	340m	225m	99m	230m	104m	19m
Receivables	225m	230m	231m

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	271m	207m
Depreciation and amortisation	22m	32m
Share-based compensation	18m	12m
Investing cash flow	−18m	−35m
Share buybacks	87m	2m
Financing cash flow	−107m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)